Table 4.
Concentrated insulins currently available in the United States.
| Insulin Name | Concentration | Brand Name | Insulin Type | Notes |
|---|---|---|---|---|
| Bioequivalent to reference 100 U/mL | • Equivalent time-action profiles. • No dose adjustment needed. | |||
| Insulin lispro | 200 U/mL | Humalog® | Prandial analog | |
| Insulin degludec | 200 U/mL | Tresiba® | Basal analog | |
| Nonbioequivalent to reference 100 U/mL | • Different time-action profiles. • Dose adjustment needed for U-300. • No dose adjustment required for U-500R. | |||
| Insulin glargine | 300 U/mL | Toujeo® | Basal analog | |
| Human regular insulin | 500 U/mL | Humulin® R U-500 | Prandial/basal human |